1. Clinical Overview
A fixed-dose combination oral antibiotic consisting of Cefpodoxime Proxetil, a third-generation cephalosporin prodrug, and Clavulanic Acid, a beta-lactamase inhibitor. This combination extends the antibacterial spectrum of cefpodoxime by protecting it from degradation by beta-lactamase enzymes produced by resistant bacteria, making it effective against a broader range of infections, particularly in the Indian context where beta-lactamase resistance is prevalent.
| Onset | Duration | Bioavailability |
|---|---|---|
| 1-2 hours | Approximately 12 hours (twice-daily dosing) | Cefpodoxime: ~50% (as cefpodoxime). Clavulanic Acid: ~60%. |
2. Mechanism of Action
Cefpodoxime binds to penicillin-binding proteins (PBPs) on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis, leading to cell lysis and death. Clavulanic acid is a 'suicide' inhibitor that irreversibly binds to and inactivates a wide range of beta-lactamase enzymes (including plasmid-mediated TEM-1, SHV-1, and some ESBLs), thereby protecting cefpodoxime from hydrolysis.
3. Indications & Uses
- Acute Bacterial Sinusitis
- Community-Acquired Pneumonia (mild to moderate)
- Acute Exacerbation of Chronic Bronchitis
- Uncomplicated Skin and Skin Structure Infections
- Uncomplicated Urinary Tract Infections (cystitis)
- Acute Otitis Media (in pediatric patients)
4. Dosage & Administration
Adult Dosage: One tablet (Cefpodoxime 200mg + Clavulanic Acid 125mg) every 12 hours. Duration: 5-14 days depending on infection.
Administration: Administer with food to enhance absorption and minimize potential gastrointestinal upset. Tablet should be swallowed whole with a full glass of water. Do not crush or chew.
5. Side Effects
Common side effects may include:
- Diarrhea or loose stools
- Nausea
- Vomiting
- Abdominal pain/discomfort
- Headache
- Vaginal candidiasis or itching
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Probenecid | Inhibits renal tubular secretion of cefpodoxime, increasing and prolonging its blood levels. | Moderate |
| Antacids, H2 Blockers (e.g., Ranitidine), PPIs (e.g., Omeprazole) | Reduce gastric acidity, which may decrease the absorption and bioavailability of cefpodoxime. Separate administration by at least 2 hours. | Moderate |
| Aminoglycosides (e.g., Gentamicin) | Increased potential for nephrotoxicity. Monitor renal function. | Moderate |
| Loop Diuretics (e.g., Furosemide) | May increase the risk of nephrotoxicity. | Moderate |
| Oral Anticoagulants (e.g., Warfarin) | May potentiate anticoagulant effect, increasing risk of bleeding. Monitor INR. | Major |
| Oral Typhoid Vaccine | Antibiotics may render the live bacterial vaccine ineffective. Avoid concurrent use. | Major |
| Methotrexate | May decrease renal clearance of methotrexate, increasing toxicity risk. | Major |
7. Patient Counselling
- DO take the medication with food to improve absorption.
- DO complete the full prescribed course, even if you feel better.
- DO inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.
- DO drink plenty of fluids.
- DO NOT skip doses. If you miss a dose, take it as soon as you remember, unless it's almost time for the next dose. Do not double the dose.
- DO NOT share your medication with others.
- DO NOT take antacids or iron supplements within 2 hours of this medicine.
8. Toxicology & Storage
Overdose: Nausea, vomiting, epigastric distress, diarrhea, and convulsions (especially in renal impairment). Hematological abnormalities are possible.
Storage: Store below 30°C. Protect from light and moisture. Keep the tablet in the blister pack until use. Keep out of reach of children. Do not use after the expiry date printed on the pack.